A patient with Creutzfeldt-Jakob disease – a case report Case report

Main Article Content

Tamara Niedźwiecka

Abstract

Creutzfeldt-Jakob diesease is a fatal neurodegenerative disorder caused by protein called prion, which as a normal prion protein converted into a disease-related isoform. Sporadic CJD is a most common form of the disease and is estimated at about 90% of all recognized CJD cases. Due to heterogenous clinical presentation the disease is difficult to diagnose. This articule presents a clinical case of the patient hospitalized at the Neurology Department at a specialist hospital in Wrocław, Poland. The standard diagnostic procedure available in Poland were used in this case. The 14-3-3 protein released into the cerebrospinal fluid can be found in a number of different neurological disorders compared to a RT-QuIC – high diagnostic value analysis – that detects an abnormal prion protein and is a specific marker for CJD with its sensivity at 85% and its specificity at 100%.

Article Details

Section
Articles

References

1. Stępień A (ed). Neurologia. Medical Tribune, Warszawa 2014: 125-8.
2. Turaj W (ed). Merritt Neurologia. Urban&Partner, Wrocław 2017: 648-57.
3. National Creutzfeldt-Jakob Disease Surveillance Diagnostic Criteria. National Creutzfeldt-Jakob Disease Surveillance (access: 3.10.2022).
4. Ryglewicz D (ed). Atlas Neurologii Klinicznej. Urban&Partner, Warszawa 2012: 361-8.
5. Zerr I, Pocchiari M, Collins S et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000; 55: 811-5.
6. Peden AH, McGuire LI, Appleford NE. Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion. J Gen Virol. 2012; 93: 438-49.
7. McGuire L, Peden AD, Orru C et al. Real Time Quaking-Induced Conversion Analysis of Cerebrospinal Fluid in Sporadic Creutzfeldt-Jakob Disease. American Neurological Association. 2012; 72: 278-85.
8. Green AJE. RT-QuIC: a new test for sporadic CJD. Pract Neurol. 2019; 19: 49-55.